<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01191632</url>
  </required_header>
  <id_info>
    <org_study_id>S081/2008</org_study_id>
    <nct_id>NCT01191632</nct_id>
  </id_info>
  <brief_title>Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases</brief_title>
  <official_title>Randomised Controlled Phase I/II Trail to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation Therapy in Resectable Colorectal Liver Metastases Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The efficiency of T cell based immunotherapies is affected by the insufficient migration and
      activity of tumor specific effector T cells in the tumor. Aim of this phase I/II clinical
      trial is to evaluate whether a neoadjuvant, low dose radiotherapy can improve T cell
      connected anti tumor immune response in colorectal liver metastases.

      The primary endpoint is the number of tumor infiltrating T cells. Furthermore the T cell
      activity in situ, the number of regulatory T cells and the frequency of tumor reactive T
      cells in the blood and bone marrow will be examined.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Purpose of the study is the determination of an active local external beam radiotherapy dose leading to a maximal number of tumor infiltrating T-cells. The total T-cell activity serves as primary surrogate parameters for anti- tumor activity</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine local control and recurrence patterns of colorectal liver metastases in a CT</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the progression-free survival in patients treated with low dose photon beam radiation therapy</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• To determine the surgical morbidity in patients undergoing liver resection who received this protocol treatment</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• To determine 30-day post-operative mortality after liver resection in patients who received this protocol treatment</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• To determine the T-cell activity in the resected liver tissue</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• To determine quality of life according to the EORTC QoL questionnaire after 6 months.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the number of regulatory T-cells in the resected liver tissue</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the frequencies of tumor-reactive T-cells in the blood and bone marrow of the patients</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine quality of life according to the EORTC QoL questionnaire after 12 months.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the number of patients with adverse events as a measure of safety and tolerability according to CTCAE, Version 4.0 criteria</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Colorectal Liver Metastases</condition>
  <arm_group>
    <arm_group_label>Radiation 0,5Gy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiation: one time Radiation with an intensity of 0.5 Gy Group A
Beginning on a weekday 48 hours before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No radiation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group with 0Gy radiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiation 2Gy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiation: one time Radiation with an intensity of
2.0 Gy Group B
Beginning on a weekday 48 hours before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiation 5Gy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiation: one time Radiation with an intensity of
5 Gy Group C Beginning on a weekday 48 hours before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>one time radiation</intervention_name>
    <description>Radiation: one time Radiation with an intensity of
0.5 Gy Group A 2.0 Gy Group B 5 Gy Group C Beginning on a weekday 48 hours before surgery</description>
    <arm_group_label>Radiation 0,5Gy</arm_group_label>
    <arm_group_label>Radiation 2Gy</arm_group_label>
    <arm_group_label>Radiation 5Gy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>No Radiation</intervention_name>
    <description>Control group with 0Gy</description>
    <arm_group_label>No radiation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability of subject to understand character and individual consequences of the clinical
             trial

          -  Written informed consent (must be available before enrolment in the trial)

          -  Age ≥ 50 years

          -  Radiological urgently suspected colorectal liver metastasis

        Exclusion Criteria:

          -  second malignancy

          -  Pregnancy and lactation

          -  no prior liver radiation

          -  liver metastasis must be resectable
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Juergen Weitz, MD</last_name>
    <phone>+49 6221 56 6250</phone>
    <email>juergen.weitz@med.uni-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph Reissfelder, MD</last_name>
    <phone>+49 6221 56 6250</phone>
    <email>christoph.reissfelder@med.uni-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juergen Weitz</last_name>
      <phone>+49 6221 56 6250</phone>
      <email>juergen.weitz@med.uni-heidelberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Christoph Reissfelder</last_name>
      <phone>+49 6221 56 6250</phone>
      <email>christoph.reissfelder@med.uni-heidelberg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2010</study_first_submitted>
  <study_first_submitted_qc>August 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2010</study_first_posted>
  <last_update_submitted>October 21, 2010</last_update_submitted>
  <last_update_submitted_qc>October 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Juergen Weitz</name_title>
    <organization>Department of surgery, university of Heidelberg</organization>
  </responsible_party>
  <keyword>T cell</keyword>
  <keyword>surgery</keyword>
  <keyword>radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

